Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01465152
Recruitment Status : Completed
First Posted : November 4, 2011
Last Update Posted : February 20, 2017
Information provided by (Responsible Party):
Novo Nordisk A/S

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 21, 2004
  Actual Study Completion Date : October 21, 2004